Apmonia Therapeutics

Reims, France · Founded 2019 · Privately Held (backing)

Developer of peptide-based biotechnology designed to provide therapeutic strategies for multiple types of cancer. Apmonia Therapeutics is based in Reims, France and was founded in 2019. Its last reported valuation was $26.8 million in Oct 2025. It has raised $23.9 million.

Last reported valuation
$26.8M
Oct 2026
Priced at
—
Total raised
$23.9M
Last round
—

Who backs Apmonia Therapeutics?

12 investors
InvestorType
BpifranceOther
European Innovation CouncilVenture capital
Capital Grand EstPE / buyout
Angels Santé—
Business Angels Marne Ardennes—
Capital Cell—
European Innovation Council (Belgium)—
Finovam Gestion—
Fournier-Majoie Foundation—
Innovact—
+ 2 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Apmonia Therapeutics investors

12 investors are on record for Apmonia Therapeutics, including Bpifrance, European Innovation Council, Capital Grand Est and Angels Santé.

Free account
More of Apmonia Therapeutics with a free account
  • ·The complete investor list: 12 names
  • ·Watch Apmonia Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 12 firms already write checks for companies like Apmonia Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View